These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38183685)

  • 1. Novel GSH-responsive prodrugs derived from indole-chalcone and camptothecin trigger apoptosis and autophagy in colon cancer.
    Wang H; Nie C; Luo M; Bai Q; Yao Z; Lv H; Chen B; Wang J; Xu W; Wang S; Chen X
    Bioorg Chem; 2024 Feb; 143():107056. PubMed ID: 38183685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel-induced apoptosis is blocked by camptothecin in human breast and pancreatic cancer cells.
    Jeansonne DP; Koh GY; Zhang F; Kirk-Ballard H; Wolff L; Liu D; Eilertsen K; Liu Z
    Oncol Rep; 2011 May; 25(5):1473-80. PubMed ID: 21331447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells.
    Bao Y; Guo Y; Zhuang X; Li D; Cheng B; Tan S; Zhang Z
    Mol Pharm; 2014 Sep; 11(9):3196-209. PubMed ID: 25102234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pH/ROS cascade-responsive and self-accelerating drug release nanosystem for the targeted treatment of multi-drug-resistant colon cancer.
    Chang N; Zhao Y; Ge N; Qian L
    Drug Deliv; 2020 Dec; 27(1):1073-1086. PubMed ID: 32706272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjudin-loaded redox-sensitive paclitaxel-prodrug micelles for overcoming multidrug resistance with efficient targeted Colon cancer therapy.
    Chen D; Ge S; Zuo L; Wang S; Liu M; Li S
    Drug Deliv; 2020 Dec; 27(1):1094-1105. PubMed ID: 32706289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
    Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Indole-Chalcone Derivative-Ligated Platinum(IV) Prodrugs Attenuate Cisplatin Resistance in Lung Cancer through ROS/ER Stress and Mitochondrial Dysfunction.
    Liu Z; Wang M; Huang R; Hu T; Jing Y; Huang X; Hu W; Cao G; Wang H
    J Med Chem; 2023 Apr; 66(7):4868-4887. PubMed ID: 36946996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced absorption, and efficacy of oral self-assembled paclitaxel nanocochleates in multi-drug resistant colon cancer.
    Shanmugam T; Joshi N; Ahamad N; Deshmukh A; Banerjee R
    Int J Pharm; 2020 Aug; 586():119482. PubMed ID: 32492505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl) imidazol (BZML) targets tubulin and DNA to induce anticancer activity and overcome multidrug resistance in colorectal cancer cells.
    Bai Z; Liu X; Guan Q; Ding N; Wei Q; Tong B; Zhao M; Zhang W; Ma L
    Chem Biol Interact; 2020 Jan; 315():108886. PubMed ID: 31682804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PSMA-Oriented Target Delivery of Novel Anticancer Prodrugs: Design, Synthesis, and Biological Evaluations of Oligopeptide-Camptothecin Conjugates.
    Xu B; Zhou F; Yan MM; Cai DS; Guo WB; Yang YQ; Jia XH; Zhang WX; Li T; Ma T; Wang PL; Lei HM
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Platinum(IV) complexes intervene oxaliplatin resistance in colon cancer via inducing ferroptosis and apoptosis.
    Liu Z; Cai J; Jiang G; Wang M; Wu C; Su K; Hu W; Huang Y; Yu C; Huang X; Cao G; Wang H
    Eur J Med Chem; 2024 Jan; 263():115968. PubMed ID: 37995563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effect of DX-8951, a novel camptothecin analog, on human pancreatic tumor cells and their CPT-11-resistant variants cultured in vitro and xenografted into nude mice.
    Takiguchi S; Kumazawa E; Shimazoe T; Tohgo A; Kono A
    Jpn J Cancer Res; 1997 Aug; 88(8):760-9. PubMed ID: 9330608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferrocene-cinchona hybrids with triazolyl-chalcone linkers act as pro-oxidants and sensitize human cancer cell lines to paclitaxel.
    Podolski-Renić A; Bősze S; Dinić J; Kocsis L; Hudecz F; Csámpai A; Pešić M
    Metallomics; 2017 Aug; 9(8):1132-1141. PubMed ID: 28737782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controllable release of self-assembled reduction-sensitive paclitaxel dimer prodrug and tetrandrine nanoparticles promotes synergistic therapy against multidrug-resistant cancer.
    Li X; Qin Z; Yuan Q; Song Y; Xu Q; Yang J; Deng X
    Biochim Biophys Acta Gen Subj; 2023 Jul; 1867(7):130362. PubMed ID: 37031808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of human colon cancer xenografts with TRA-8 anti-death receptor 5 antibody alone or in combination with CPT-11.
    Oliver PG; LoBuglio AF; Zinn KR; Kim H; Nan L; Zhou T; Wang W; Buchsbaum DJ
    Clin Cancer Res; 2008 Apr; 14(7):2180-9. PubMed ID: 18381960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A camptothecin prodrug induces mitochondria-mediated apoptosis in cancer cells with cascade activations.
    Luo X; Chi X; Lin Y; Yang Z; Lin H; Gao J
    Chem Commun (Camb); 2021 Oct; 57(84):11033-11036. PubMed ID: 34608474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibitory effect of a new camptothecin analog, DX-8951f, on various drug-resistant sublines including BCRP-mediated camptothecin derivative-resistant variants derived from the human lung cancer cell line PC-6.
    Ishii M; Iwahana M; Mitsui I; Minami M; Imagawa S; Tohgo A; Ejima A
    Anticancer Drugs; 2000 Jun; 11(5):353-62. PubMed ID: 10912951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure optimization of an F-indole-chalcone (FC116) on 4-methoxyphenyl group and therapeutic potential against colorectal cancers with low cytotoxicity.
    Du B; Liu X; Luan X; Zhang W; Zhuang C
    Bioorg Chem; 2023 Jun; 135():106531. PubMed ID: 37043882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-homing peptide iRGD-conjugate enhances tumor accumulation of camptothecin for colon cancer therapy.
    Singh T; Kim TW; Murthy ASN; Paul M; Sepay N; Jeong Kong H; Sung Ryu J; Rim Koo N; Yoon S; Song KH; Jun Baek M; Jeon S; Im J
    Eur J Med Chem; 2024 Feb; 265():116050. PubMed ID: 38128233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A personalized and long-acting local therapeutic platform combining photothermal therapy and chemotherapy for the treatment of multidrug-resistant colon tumor.
    Wang B; Wu S; Lin Z; Jiang Y; Chen Y; Chen ZS; Yang X; Gao W
    Int J Nanomedicine; 2018; 13():8411-8427. PubMed ID: 30587968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.